When inspecting the results above, we particularly noticed that genes involved in the ADRB1-mediated cAMP signaling pathway were dramatically up-regulated in BRCA1-deficient ovarian cancer patients (Figures 3D,G). This evidence concerns the gene BRCA1 and ovarian cancer.